Medtronic Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One decreased by 0.3% to $1.55B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $1.56B to $1.55B.
Higher values indicate a larger portion of the portfolio is liquid and available for reinvestment or cash needs in the short term.
This represents the amortized cost of debt securities in the available-for-sale portfolio that are scheduled to mature w...
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_with_72951f| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $1.46B | $1.49B | $1.56B | $1.43B | $1.56B | $1.55B |
| QoQ Change | — | +1.8% | +4.8% | -8.2% | +8.9% | -0.3% |
| YoY Change | — | — | — | -2.1% | +4.8% | -0.4% |